FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Fernando Cabanillas

Research Profile

Procedures

Disorders

Chemicals & Drugs

Concepts & Ideas

Phenomena

Recurrence

Co-author Network

Publications

TOP 3
Michael Wang; Anas Younes; Ken H Young; Jerome Zeldis; Liang Zhang; Felipe Samaniego; Luhong Sun; Nicolaus Wagner-Bartak; Maria Badillo; Maria Bejarano; Neda Bell; Catriona Byrne; Fernando Cabanillas; Richard Champlin; Wendy Chen; Yiming Chen; Michelle A Fanale; Luis Fayad; Lei Feng; Nathan Fowler; Fredrick Hagemeister; Kimberly Hartig; Larry W Kwak; Peter McLaughlin; Sattva S Neelapu; Kate J Newberry; Jorge Romaguera
Lenalidomide in combination with rituximab for patients with relapsed or refractory mantle-cell lymphoma: a phase 1/2 clinical trial.
Fernando Cabanillas; Mariely Nieves-Plaza; Gerardo Quevedo; Ignacio A Echenique
Rectal adenocarcinoma: proposal for a model based on pretreatment prognostic factors.
Maria Y Giraldo-Jiménez; Vanessa Marcial; Pablo Mojica; Viviana Negrón; Karen Santiago; Rafael Vaquer; Fernando Cabanillas; Miguel Echenique; Victor Carlo-Vargas
Triple negative breast cancer: a retrospective study of Hispanics residing in Puerto Rico.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Fernando Cabanillas (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Michael Wang; Anas Younes; Ken H Young; Jerome Zeldis; Liang Zhang; Felipe Samaniego; Luhong Sun; Nicolaus Wagner-Bartak; Maria Badillo; Maria Bejarano; Neda Bell; Catriona Byrne; Fernando Cabanillas; Richard Champlin; Wendy Chen; Yiming Chen; Michelle A Fanale; Luis Fayad; Lei Feng; Nathan Fowler; Fredrick Hagemeister; Kimberly Hartig; Larry W Kwak; Peter McLaughlin; Sattva S Neelapu; Kate J Newberry; Jorge Romaguera
Lenalidomide in combination with rituximab for patients with relapsed or refractory mantle-cell lymphoma: a phase 1/2 clinical trial.
The lancet oncology 2012;13(7):716-23.
2012: Fernando Cabanillas; Mariely Nieves-Plaza; Gerardo Quevedo; Ignacio A Echenique
Rectal adenocarcinoma: proposal for a model based on pretreatment prognostic factors.
Puerto Rico health sciences journal 2012;31(2):52-8.
2012: Maria Y Giraldo-Jiménez; Vanessa Marcial; Pablo Mojica; Viviana Negrón; Karen Santiago; Rafael Vaquer; Fernando Cabanillas; Miguel Echenique; Victor Carlo-Vargas
Triple negative breast cancer: a retrospective study of Hispanics residing in Puerto Rico.
Puerto Rico health sciences journal 2012;31(2):45-51.
2011: Fernando Cabanillas
Rituximab in DLBCL: 6 years on.
The lancet oncology 2011;12(11):984-5.
2011: Norman I Maldonado; Mark Raffeld; Fernando Cabanillas; Elaine S Jaffe; Luis Lozada
Successful treatment of a patient with Epstein-Barr virus-positive B-cell lymphoproliferative disorder resembling post-transplant lymphoproliferative disorder using single-agent rituximab.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(22):e658-60.
2011: David R Fogelman; Robert A Wolff; Scott Kopetz; Milind Javle; Charles Bradley; Isabel Mok; Fernando Cabanillas; James L Abbruzzese
Evidence for the efficacy of Iniparib, a PARP-1 inhibitor, in BRCA2-associated pancreatic cancer.
Anticancer research 2011;31(4):1417-20.
2010: Fernando Cabanillas
How important is whole brain radiotherapy for treatment of primary CNS lymphoma?
The lancet oncology 2010;11(11):1011-2.
2010: Fernando Cabanillas
Front-line management of diffuse large B cell lymphoma.
Current opinion in oncology 2010;22(6):642-5.
2010: Jorge Romaguera; Luis Fayad; Lei Feng; Kimberly Hartig; Pamela Weaver; Maria Alma Rodriguez; Fredrick B Hagemeister; Barbara Pro; Peter McLaughlin; Anas Younes; Felipe Samaniego; Andre Goy; Fernando Cabanillas; Andrew Lamb; Larry Kwak; Michael Wang
Ten-year follow-up after intense chemoimmunotherapy with Rituximab-HyperCVAD alternating with Rituximab-high dose methotrexate/cytarabine (R-MA) and without stem cell transplantation in patients with untreated aggressive mantle cell lymphoma.
British journal of haematology 2010;150(2):200-8.
2009: Bita Esmaeli; Peter McLaughlin; Barbara Pro; Felipe Samaniego; Isis Gayed; Fredrick Hagemeister; Jorge Romaguera; Fernando Cabanillas; Sattva S Neelapu; R Banay; Luis Fayad; M Wayne Saville; Larry W Kwak
Prospective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (Zevalin) for front-line treatment of early-stage extranodal indolent ocular adnexal lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(4):709-14.
2008: Michael Wang; Luis Fayad; Fernando Cabanillas; Fredrick Hagemeister; Peter McLaughlin; Maria A Rodriguez; Larry W Kwak; Yuhong Zhou; Andrew Lamb; Jorge Romaguera
Phase 2 trial of rituximab plus hyper-CVAD alternating with rituximab plus methotrexate-cytarabine for relapsed or refractory aggressive mantle cell lymphoma.
Cancer 2008;113(10):2734-41.
2008: M J Overman; L Feng; Barbara Pro; Peter McLaughlin; Mark Hess; Felipe Samaniego; Anas Younes; Jorge Romaguera; Fredrick B Hagemeister; Larry W Kwak; Fernando Cabanillas; Maria A Rodriguez; Luis Fayad
The addition of rituximab to CHOP chemotherapy improves overall and failure-free survival for follicular grade 3 lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(3):553-9.
2006: Carlo Visco; Gianpaolo Nadali; Theodoros P Vassilakopoulos; Valeria Bonfante; Simonetta Viviani; ALESSANDRO MASSIMO GIANNI; Massimo Federico; stefano luminari; Prema P Peethambaram; Thomas E Witzig; Gerassimos A Pangalis; Fernando Cabanillas; L Jeffrey Medeiros; Andreas H Sarris; Giovanni Pizzolo
Very high levels of soluble CD30 recognize the patients with classical Hodgkin's lymphoma retaining a very poor prognosis.
European journal of haematology 2006;77(5):387-94.
2006: Barbara Pro; Fredrick B Hagemeister; Peter McLaughlin; Jorge Romaguera; Maria A Rodriguez; Fernando Cabanillas; Lili Paz Tiongson; Anas Younes
Phase 2 study of fludarabine and paclitaxel in patients with recurrent low-grade non-Hodgkin's lymphoma.
Leukemia & lymphoma 2006;47(9):1818-21.
2006: Qi Liu; Luis Fayad; Fernando Cabanillas; Fredrick B Hagemeister; Gregory D Ayers; Mark Hess; Jorge Romaguera; Maria A Rodriguez; Apostolia-Maria Tsimberidou; Srdan Verstovsek; Anas Younes; Barbara Pro; Ming-Sheng Lee; Ana Ayala; Peter McLaughlin
Improvement of overall and failure-free survival in stage IV follicular lymphoma: 25 years of treatment experience at The University of Texas M.D. Anderson Cancer Center.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(10):1582-9.
2006: Deborah A Thomas; Stefan Faderl; Susan O'Brien; Carlos E Bueso-Ramos; Jorge Cortes; Guillermo Garcia-Manero; Francis Giles; Srdan Verstovsek; William G Wierda; Sherry A Pierce; Jianqin Shan; Mark Brandt; Fredrick B Hagemeister; Michael J Keating; Fernando Cabanillas; Andrew Lamb
Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia.
Cancer 2006;106(7):1569-80.
2006: Deborah A Thomas; Andreas H Sarris; Jorge Cortes; Stefan Faderl; Susan O'Brien; Francis Giles; Guillermo Garcia-Manero; Maria A Rodriguez; Fernando Cabanillas; Andrew Lamb
Phase II study of sphingosomal vincristine in patients with recurrent or refractory adult acute lymphocytic leukemia.
Cancer 2006;106(1):120-7.
2005: Jorge Romaguera; Luis Fayad; Maria A Rodriguez; Kristine Broglio; Fredrick B Hagemeister; Barbara Pro; Peter McLaughlin; Anas Younes; Felipe Samaniego; Andre Goy; Andreas H Sarris; Nam H Dang; Michael Wang; Virginia Beasley; L Jeffrey Medeiros; Ruth Katz; Harish K Gagneja; Barry Samuels; Terry L Smith; Fernando Cabanillas
High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(28):7013-23.
2005: Chul Ha; Fernando Cabanillas; Ming S Lee; Susan L Tucker; Peter McLaughlin; Maria A Rodriguez; Anas Younes; Jorge Romaguera; Ofelia M Mesina; James D Cox
A prospective randomized study to compare the molecular response rates between central lymphatic irradiation and intensive alternating triple chemotherapy in the treatment of stage I-III follicular lymphoma.
International journal of radiation oncology, biology, physics 2005;63(1):188-93.
2005: Apostolia-Maria Tsimberidou; Anas Younes; Jorge Romaguera; Fredrick B Hagemeister; Maria A Rodriguez; Lei Feng; Ana Ayala; Terry L Smith; Fernando Cabanillas; Peter McLaughlin
Immunosuppression and infectious complications in patients with stage IV indolent lymphoma treated with a fludarabine, mitoxantrone, and dexamethasone regimen.
Cancer 2005;104(2):345-53.
2005: Fredrick Hagemeister; Fernando Cabanillas; Morton Coleman; Stephanie A Gregory; Pier Luigi Zinzani
The role of mitoxantrone in the treatment of indolent lymphomas.
The oncologist 2005;10(2):150-9.
2005: Andre Goy; Anas Younes; Peter McLaughlin; Barbara Pro; Jorge Romaguera; Fredrick Hagemeister; Luis Fayad; Nam H Dang; Felipe Samaniego; Michael Wang; Kristine Broglio; Barry Samuels; Frederic Gilles; Andreas H Sarris; Susan Hart; Elizabeth Trehu; David P Schenkein; Fernando Cabanillas; Alma M Rodriguez
Phase II study of proteasome inhibitor bortezomib in relapsed or refractory B-cell non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(4):667-75.
2004: Carlo Visco; Theodoros P Vassilakopoulos; Kay-Oliver Kliche; Gianpaolo Nadali; Simonetta Viviani; Valeria Bonfante; L Jeffrey Medeiros; P Notti; George Z Rassidakis; Prema P Peethambaram; Richard Wilder; Thomas E Witzig; ALESSANDRO MASSIMO GIANNI; Gianni Bonadonna; Giovanni Pizzolo; Gerassimos A Pangalis; Fernando Cabanillas; Andreas H Sarris
Elevated serum levels of IL-10 are associated with inferior progression-free survival in patients with Hodgkin's disease treated with radiotherapy.
Leukemia & lymphoma 2004;45(10):2085-92.
2004: Deborah A Thomas; Susan O'Brien; Jorge Cortes; Francis Giles; Stefan Faderl; Srdan Verstovsek; Alessandra Ferrajoli; Charles Koller; Miloslav Beran; Sherry Pierce; Chul Ha; Fernando Cabanillas; Michael J Keating; Andrew Lamb
Outcome with the hyper-CVAD regimens in lymphoblastic lymphoma.
Blood 2004;104(6):1624-30.
2004: Anas Younes; Barbara Pro; Michael J Robertson; Ian W Flinn; Jorge Romaguera; Fredrick Hagemeister; Nam H Dang; Paolo Fiumara; Evelyne M Loyer; Fernando Cabanillas; Peter W McLaughlin; Maria A Rodriguez; Felipe Samaniego
Phase II clinical trial of interleukin-12 in patients with relapsed and refractory non-Hodgkin's lymphoma and Hodgkin's disease.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(16):5432-8.
2004: Andre Goy; Yvonne K Remache; Jun Gu; John Stewart; Kimberly J Hayes; David Gold; Yunfang Jiang; Bedia A Barkoh; Ruth Katz; Fernando Cabanillas; Frederic Gilles
Establishment and characterization of a new mantle cell lymphoma cell line M-1.
Leukemia & lymphoma 2004;45(6):1255-60.
2004: Uday Popat; Chitra Hosing; Rima M Saliba; Paolo Anderlini; Koen van Besien; Donna Przepiorka; Issa F Khouri; James L Gajewski; David F Claxton; Sergio Giralt; M Rodriguez; Jorge Romaguera; Fredrick Hagemeister; Chul Ha; J Cox; Fernando Cabanillas; Borje S Andersson; Richard E Champlin
Prognostic factors for disease progression after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for recurrent or refractory Hodgkin's lymphoma.
Bone marrow transplantation 2004;33(10):1015-23.
2004: Barbara Pro; Anas Younes; Maher Albitar; Nam H Dang; Felipe Samaniego; Jorge Romaguera; Peter McLaughlin; Fredrick B Hagemeister; Maria A Rodriguez; Marilyn Clemons; Fernando Cabanillas
Thalidomide for patients with recurrent lymphoma.
Cancer 2004;100(6):1186-9.
2004: Gregory M Chronowski; Richard B Wilder; Lawrence B Levy; E Neely Atkinson; Chul Ha; Fredrick B Hagemeister; Ibrahim Barista; Maria A Rodriguez; Andreas H Sarris; Mark A Hess; Fernando Cabanillas; James D Cox
Second malignancies after chemotherapy and radiotherapy for Hodgkin disease.
American journal of clinical oncology 2004;27(1):73-80.
2004: Chul Ha; Ming-Sheng Lee; Peter McLaughlin; Susan L Tucker; Richard B Wilder; James D Cox; Fernando Cabanillas
Molecular response of follicular lymphoma to cyclophosphamide, doxorubicin, vincristine, prednisone C(H)OP or COP-based therapy as measured by polymerase chain reaction evidence of translocation (14;18)(q32;q21).
Cancer journal (Sudbury, Mass.) 2004;10(1):49-53.
2003: Chul Ha; Joseph S Kong; Peter McLaughlin; Susan L Tucker; Luis Fayad; Mark A Hess; Richard B Wilder; Fernando Cabanillas; James D Cox
Stage III follicular lymphoma: long-term follow-up and patterns of failure.
International journal of radiation oncology, biology, physics 2003;57(3):748-54.
2003: Chul Ha; Joseph S Kong; Susan L Tucker; Peter McLaughlin; Richard B Wilder; Mark A Hess; Fernando Cabanillas; James D Cox
Central lymphatic irradiation for stage I-III follicular lymphoma: report from a single-institutional prospective study.
International journal of radiation oncology, biology, physics 2003;57(2):316-20.
2003: Bouthaina S Dabaja; Peter McLaughlin; Chul Ha; Barbara Pro; Christina A Meyers; Lee F Seabrooke; Richard B Wilder; Athanassios P Kyritsis; H Alejandro Preti; W K Alfred Yung; Victor Levin; Fernando Cabanillas; James D Cox
Primary central nervous system lymphoma: Phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemotherapy.
Cancer 2003;98(5):1021-8.
2003: Bouthaina S Dabaja; Chul Ha; Richard B Wilder; Barbara Pro; Peter McLaughlin; Fernando Cabanillas; James D Cox
Importance of esophagogastroduodenoscopy in the evaluation of non-gastrointestinal mucosa-associated lymphoid tissue lymphoma.
Cancer journal (Sudbury, Mass.) 2003;9(4):321-4.
2003: Andre Goy; Latha Ramdas; Yvonne K Remache; Jun Gu; Luis Fayad; Kimberly J Hayes; Kevin R Coombes; Bedia A Barkoh; Ruth Katz; Richard Ford; Fernando Cabanillas; Frederic Gilles
Establishment and characterization by gene expression profiling of a new diffuse large B-cell lymphoma cell line, EJ-1, carrying t(14;18) and t(8;14) translocations.
Laboratory investigation; a journal of technical methods and pathology 2003;83(6):913-6.
2003: George Z Rassidakis; Andre Goy; L Jeffrey Medeiros; Yunfang Jiang; Athanasios Thomaides; Yvonne K Remache; Fernando Cabanillas; Andreas H Sarris; Frederic Gilles
Prognostic significance of MUC-1 expression in systemic anaplastic large cell lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(6):2213-20.
2003: Marco Herling; George Z Rassidakis; L Jeffrey Medeiros; Theodoros P Vassilakopoulos; Kay-Oliver Kliche; Gianpaolo Nadali; Simonetta Viviani; Valeria Bonfante; Roberto Giardini; Marco Chilosi; Christos Kittas; ALESSANDRO MASSIMO GIANNI; Gianni Bonadonna; Giovanni Pizzolo; Gerassimos A Pangalis; Fernando Cabanillas; Andreas H Sarris
Expression of Epstein-Barr virus latent membrane protein-1 in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma: associations with presenting features, serum interleukin 10 levels, and clinical outcome.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(6):2114-20.
2003: John F Seymour; Barbara Pro; Lillian M Fuller; John T Manning; Fredrick B Hagemeister; Jorge Romaguera; Maria A Rodriguez; Chul Ha; Terry L Smith; Ana Ayala; Mark Hess; James D Cox; Fernando Cabanillas; Peter McLaughlin
Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(11):2115-22.
2003: Chitra Hosing; Rima M Saliba; Peter McLaughlin; Borje Andersson; Maria A Rodriguez; Luis Fayad; Fernando Cabanillas; Richard E Champlin; Issa F Khouri
Long-term results favor allogeneic over autologous hematopoietic stem cell transplantation in patients with refractory or recurrent indolent non-Hodgkin's lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(5):737-44.
2003: Raymond Alexanian; Donna Weber; Kay Delasalle; Fernando Cabanillas; Meletios A Dimopoulos
Asymptomatic Waldenstrom's macroglobulinemia.
Seminars in oncology 2003;30(2):206-10.
2003: Jorge Romaguera; L Jeffrey Medeiros; Fredrick B Hagemeister; Luis Fayad; Maria A Rodriguez; Barbara Pro; Anas Younes; Peter McLaughlin; Andre Goy; Andreas H Sarris; Nam H Dang; Felipe Samaniego; H M Brown; Harish K Gagneja; Fernando Cabanillas
Frequency of gastrointestinal involvement and its clinical significance in mantle cell lymphoma.
Cancer 2003;97(3):586-91.
2003: Gregory M Chronowski; Richard B Wilder; Susan L Tucker; Chul Ha; Anas Younes; Luis Fayad; Maria A Rodriguez; Fredrick B Hagemeister; Ibrahim Barista; Fernando Cabanillas; James D Cox
Analysis of in-field control and late toxicity for adults with early-stage Hodgkin's disease treated with chemotherapy followed by radiotherapy.
International journal of radiation oncology, biology, physics 2003;55(1):36-43.
2002: Gregory M Chronowski; Richard B Wilder; Susan L Tucker; Chul Ha; Andreas H Sarris; Fredrick B Hagemeister; Ibrahim Barista; Mark A Hess; Fernando Cabanillas; James D Cox
An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease.
Cancer 2002;95(12):2534-8.
2002: Apostolia-Maria Tsimberidou; Peter McLaughlin; Anas Younes; Maria A Rodriguez; Fredrick B Hagemeister; Andreas H Sarris; Jorge Romaguera; Mark Hess; Terry L Smith; Ying Yang; Ana Ayala; Alejandro Preti; Ming-Sheng Lee; Fernando Cabanillas
Fludarabine, mitoxantrone, dexamethasone (FND) compared with an alternating triple therapy (ATT) regimen in patients with stage IV indolent lymphoma.
Blood 2002;100(13):4351-7.
2002: George Z Rassidakis; L Jeffrey Medeiros; Theodoros P Vassilakopoulos; Simonetta Viviani; Valeria Bonfante; Gianpaolo Nadali; Marco Herling; Maria K Angelopoulou; Roberto Giardini; Marco Chilosi; Christos Kittas; Timothy J McDonnell; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI; Giovanni Pizzolo; Gerassimos A Pangalis; Fernando Cabanillas; Andreas H Sarris
BCL-2 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease predicts a poorer prognosis in patients treated with ABVD or equivalent regimens.
Blood 2002;100(12):3935-41.
2002: Hoon K Lee; Richard B Wilder; Dan Jones; Chul Ha; Barbara Pro; Maria A Rodriguez; Jorge Romaguera; Fernando Cabanillas; Jose Rodriguez; James D Cox
Outcomes using doxorubicin-based chemotherapy with or without radiotherapy for early-stage peripheral T-cell lymphomas.
Leukemia & lymphoma 2002;43(9):1769-75.
2002: Pamela J Schlembach; Richard B Wilder; Dan Jones; Chul Ha; Luis Fayad; Anas Younes; Fredrick Hagemeister; Mark Hess; Fernando Cabanillas; James D Cox
Radiotherapy alone for lymphocyte-predominant Hodgkin's disease.
Cancer journal (Sudbury, Mass.) 2002;8(5):377-83.
2002: George Z Rassidakis; Dan Jones; Athanasios Thomaides; Filiz Sen; Raymond Lai; Fernando Cabanillas; Timothy J McDonnell; L Jeffrey Medeiros
Apoptotic rate in peripheral T-cell lymphomas. A study using a tissue microarray with validation on full tissue sections.
American journal of clinical pathology 2002;118(3):328-34.
2002: Apostolia-Maria Tsimberidou; Yunfang Jiang; Richard J Ford; Benjamin Lichtiger; L Jeffrey Medeiros; Peter McLaughlin; Fernando Cabanillas; Andreas H Sarris
Quantitative real-time polymerase chain reaction for detection of circulating cells with t(14;18) in volunteer blood donors and patients with follicular lymphoma.
Leukemia & lymphoma 2002;43(8):1589-98.
2002: Andreas H Sarris; Alexandria Phan; Andre Goy; Jorge Romaguera; Fredrick B Hagemeister; Maria A Rodriguez; Peter McLaughlin; Barbara Pro; L Jeffrey Medeiros; Barry Samuels; Ofelia M Mesina; Archie Bleyer; Fernando Cabanillas
Irinotecan in relapsed or refractory non-Hodgkin's lymphomas. Indications of activity in a phase II trial.
Oncology (Williston Park, N.Y.) 2002;16(8 Suppl 7):27-31.
2002: Carlo Visco; L Jeffrey Medeiros; Dan Jones; T Smith; Maria A Rodriguez; Peter McLaughlin; Jorge Romaguera; Fernando Cabanillas; Andreas H Sarris
Primary cutaneous non-Hodgkin's lymphoma with aggressive histology: inferior outcome is associated with peripheral T-cell type and elevated lactate dehydrogenase, but not extent of cutaneous involvement.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(8):1290-9.
2002: Richard B Wilder; Maria A Rodriguez; L Jeffrey Medeiros; Susan L Tucker; Chul Ha; Jorge Romaguera; Barbara Pro; Mark A Hess; Fernando Cabanillas; James D Cox
International prognostic index-based outcomes for diffuse large B-cell lymphomas.
Cancer 2002;94(12):3083-8.
2002: Andreas H Sarris; Alexandria Phan; Madeleine Duvic; Jorge Romaguera; Peter McLaughlin; Ofelia M Mesina; K King; L Jeffrey Medeiros; George Z Rassidakis; Barry Samuels; Fernando Cabanillas
Trimetrexate in relapsed T-cell lymphoma with skin involvement.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(12):2876-80.
2002: Richard B Wilder; Pamela J Schlembach; Dan Jones; Gregory M Chronowski; Chul Ha; Anas Younes; Fredrick B Hagemeister; Ibrahim Barista; Fernando Cabanillas; James D Cox
European Organization for Research and Treatment of Cancer and Groupe d'Etude des Lymphomes de l'Adulte very favorable and favorable, lymphocyte-predominant Hodgkin disease.
Cancer 2002;94(6):1731-8.
2002: George Z Rassidakis; L Jeffrey Medeiros; Simonetta Viviani; Valeria Bonfante; Gianpaolo Nadali; Theodoros P Vassilakopoulos; Ofelia M Mesina; Marco Herling; Maria K Angelopoulou; Roberto Giardini; Marco Chilosi; Christos Kittas; Peter McLaughlin; Maria A Rodriguez; Jorge Romaguera; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI; Giovanni Pizzolo; Gerassimos A Pangalis; Fernando Cabanillas; Andreas H Sarris
CD20 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin's disease: associations with presenting features and clinical outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(5):1278-87.
2002: Ibrahim Barista; Fernando Cabanillas; Jorge Romaguera; Issa F Khouri; Y Yang; Terry L Smith; S S Strom; L Jeffrey Medeiros; Fredrick B Hagemeister
Is there an increased rate of additional malignancies in patients with mantle cell lymphoma?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(2):318-22.
2002: Richard B Wilder; Jorge Romaguera; Susan L Tucker; Chul Ha; Mark A Hess; Fernando Cabanillas; James D Cox
Results with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone followed by radiotherapy with or without prechemotherapy surgical debulking for patients with bulky, aggressive lymphoma.
Cancer 2002;94(3):601-5.
2002: Andreas H Sarris; Yunfang Jiang; Apostolia-Maria Tsimberidou; Athanasios Thomaides; George Z Rassidakis; Richard J Ford; L Jeffrey Medeiros; Fernando Cabanillas; Peter McLaughlin
Quantitative real-time polymerase chain reaction for monitoring minimal residual disease in patients with advanced indolent lymphomas treated with rituximab, fludarabine, mitoxantrone, and dexamethasone.
Seminars in oncology 2002;29(1 Suppl 2):48-55.
2002: George Z Rassidakis; L Jeffrey Medeiros; Timothy J McDonnell; Simonetta Viviani; Valeria Bonfante; Gianpaolo Nadali; Theodoros P Vassilakopoulos; Roberto Giardini; Marco Chilosi; Christos Kittas; ALESSANDRO MASSIMO GIANNI; Gianni Bonadonna; Giovanni Pizzolo; Gerassimos A Pangalis; Fernando Cabanillas; Andreas H Sarris
BAX expression in Hodgkin and Reed-Sternberg cells of Hodgkin's disease: correlation with clinical outcome.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(2):488-93.
2002: Katharina Clodi; Zahra Asgari; Mamoun Younes; J Lynn Palmer; Fernando Cabanillas; Antonino Carbone; Michael Andreeff; Anas Younes
Expression of CD40 ligand (CD154) in B and T lymphocytes of Hodgkin disease: potential therapeutic significance.
Cancer 2002;94(1):1-5.
2001: Issa F Khouri; Rima M Saliba; Sergio Giralt; Ming-Sheng Lee; Grace-Julia Okoroji; Fredrick B Hagemeister; Martin Korbling; Anas Younes; Cindy Ippoliti; James L Gajewski; Peter McLaughlin; Paolo Anderlini; Michele L Donato; Fernando Cabanillas; Richard E Champlin
Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality.
Blood 2001;98(13):3595-9.
2001: Richard B Wilder; Dan Jones; Susan L Tucker; Lillian M Fuller; Chul Ha; Peter McLaughlin; Mark A Hess; Fernando Cabanillas; James D Cox
Long-term results with radiotherapy for Stage I-II follicular lymphomas.
International journal of radiation oncology, biology, physics 2001;51(5):1219-27.
2001: Paolo Fiumara; Virginia Snell; Yang Li; A Mukhopadhyay; Mamoun Younes; Ann M Gillenwater; Fernando Cabanillas; Bharat B Aggarwal; Anas Younes
Functional expression of receptor activator of nuclear factor kappaB in Hodgkin disease cell lines.
Blood 2001;98(9):2784-90.
2001: R D Page; Jorge Romaguera; B Osborne; L Jeffrey Medeiros; J Rodriguez; LB North; C Sanz-Rodriguez; Fernando Cabanillas
Primary hepatic lymphoma: favorable outcome after combination chemotherapy.
Cancer 2001;92(8):2023-9.
2001: Ugur Aytac; Francois Claret; Linus Ho; Kazuya Sato; Kei Ohnuma; Gordon B Mills; Fernando Cabanillas; Chikao Morimoto; Nam H Dang
Expression of CD26 and its associated dipeptidyl peptidase IV enzyme activity enhances sensitivity to doxorubicin-induced cell cycle arrest at the G(2)/M checkpoint.
Cancer research 2001;61(19):7204-10.
2001: Marco Herling; George Z Rassidakis; Simonetta Viviani; Valeria Bonfante; Roberto Giardini; ALESSANDRO MASSIMO GIANNI; SW Morris; Fernando Cabanillas; L Jeffrey Medeiros; Andreas H Sarris
Anaplastic lymphoma kinase (ALK) is not expressed in Hodgkin's disease: results with ALK-11 antibody in 327 untreated patients.
Leukemia & lymphoma 2001;42(5):969-79.
2001: Chul Ha; Susan L Tucker; Angel I Blanco; Richard B Wilder; Peter McLaughlin; Fernando Cabanillas; James D Cox
Hematologic recovery after central lymphatic irradiation for patients with stage I-III follicular lymphoma.
Cancer 2001;92(5):1074-9.
2001: J Rodriguez; Mark F Munsell; Salim Yazji; Fredrick B Hagemeister; Anas Younes; Borje Andersson; Sergio Giralt; James L Gajewski; Marcos De Lima; Daniel Couriel; Jorge Romaguera; Fernando Cabanillas; Richard E Champlin; Issa F Khouri
Impact of high-dose chemotherapy on peripheral T-cell lymphomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(17):3766-70.
2001: Gregory M Chronowski; Chul Ha; Richard B Wilder; Fernando Cabanillas; J Manning; James D Cox
Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy.
Cancer 2001;92(3):670-6.
2001: George Z Rassidakis; Andreas H Sarris; Marco Herling; Richard J Ford; Fernando Cabanillas; Timothy J McDonnell; L Jeffrey Medeiros
Differential expression of BCL-2 family proteins in ALK-positive and ALK-negative anaplastic large cell lymphoma of T/null-cell lineage.
The American journal of pathology 2001;159(2):527-35.
2001: Zhongxing Liao; Chul Ha; Maria T Vlachaki; Fredrick Hagemeister; Fernando Cabanillas; Mark Hess; Susan Tucker; James D Cox
Mantle irradiation alone for pathologic stage I and II Hodgkin's disease: long-term follow-up and patterns of failure.
International journal of radiation oncology, biology, physics 2001;50(4):971-7.
2001: Anas Younes; H Alejandro Preti; Fredrick B Hagemeister; Peter McLaughlin; Jorge Romaguera; Maria A Rodriguez; Barry Samuels; J Lynn Palmer; Fernando Cabanillas
Paclitaxel plus topotecan treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(7):923-7.
2001: Andreas H Sarris; Jorge Romaguera; Fredrick B Hagemeister; Maria A Rodriguez; Peter McLaughlin; Barbara Pro; Anas Younes; Ofelia M Mesina; Fernando Cabanillas; L Jeffrey Medeiros; Barry Samuels
Irinotecan in relapsed or refractory non-Hodgkin's lymphoma.
Oncology (Williston Park, N.Y.) 2001;15(7 Suppl 8):53-6.
2001: Linus Ho; Ugur Aytac; L Clifton Stephens; Kei Ohnuma; Gordon B Mills; Kathryn S McKee; C Neumann; Ruth Lapushin; Fernando Cabanillas; James L Abbruzzese; Chikao Morimoto; Nam H Dang
In vitro and in vivo antitumor effect of the anti-CD26 monoclonal antibody 1F7 on human CD30+ anaplastic large cell T-cell lymphoma Karpas 299.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(7):2031-40.
2001: Richard B Wilder; Maria A Rodriguez; Susan L Tucker; Chul Ha; Mark A Hess; Fernando Cabanillas; James D Cox
Radiation therapy after a partial response to CHOP chemotherapy for aggressive lymphomas.
International journal of radiation oncology, biology, physics 2001;50(3):743-9.
2001: Richard B Wilder; Maria A Rodriguez; Chul Ha; Barbara Pro; Mark A Hess; Fernando Cabanillas; James D Cox
Bulky disease is an adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy for aggressive lymphoma.
Cancer 2001;91(12):2440-6.
2001: Carlo Visco; L Jeffrey Medeiros; Ofelia M Mesina; Maria A Rodriguez; Fredrick B Hagemeister; Peter McLaughlin; Jorge Romaguera; Fernando Cabanillas; Andreas H Sarris
Non-Hodgkin's lymphoma affecting the testis: is it curable with doxorubicin-based therapy?
Clinical lymphoma 2001;2(1):40-6.
2001: Apostolia-Maria Tsimberidou; Andreas H Sarris; L Jeffrey Medeiros; Ofelia M Mesina; Maria A Rodriguez; Fredrick B Hagemeister; Jorge Romaguera; Barbara Pro; Peter McLaughlin; N Dang; Fernando Cabanillas
Hodgkin's disease in patients infected with human immunodeficiency virus: frequency, presentation and clinical outcome.
Leukemia & lymphoma 2001;41(5-6):535-44.
2001: Christopher E Pelloski; Richard B Wilder; Chul Ha; Mark A Hess; Fernando Cabanillas; James D Cox
Clinical stage IEA-IIEA orbital lymphomas: outcomes in the era of modern staging and treatment.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2001;59(2):145-51.
2001: Jose Rodriguez; Jorge Romaguera; Ruth Katz; J Said; Fernando Cabanillas
Primary effusion lymphoma in an HIV-negative patient with no serologic evidence of Kaposi's sarcoma virus.
Leukemia & lymphoma 2001;41(1-2):185-9.
2001: Chul Ha; Susan L Tucker; Ming-Sheng Lee; Peter McLaughlin; Fernando Cabanillas; James D Cox
The significance of molecular response of follicular lymphoma to central lymphatic irradiation as measured by polymerase chain reaction for t(14;18)(q32;q21).
International journal of radiation oncology, biology, physics 2001;49(3):727-32.
2001: Chul Ha; K M Shadle; L Jeffrey Medeiros; Richard B Wilder; Mark A Hess; Fernando Cabanillas; James D Cox
Localized non-Hodgkin lymphoma involving the thyroid gland.
Cancer 2001;91(4):629-35.
2001: Andreas H Sarris; Ira Braunschweig; L Jeffrey Medeiros; Madeleine Duvic; Chul Ha; Maria A Rodriguez; Fredrick B Hagemeister; Peter McLaughlin; Jorge Romaguera; J Cox; Fernando Cabanillas
Primary cutaneous non-Hodgkin's lymphoma of Ann Arbor stage I: preferential cutaneous relapses but high cure rate with doxorubicin-based therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(2):398-405.
2001: Richard B Wilder; Susan L Tucker; Chul Ha; Maria A Rodriguez; Mark A Hess; Fernando Cabanillas; James D Cox
Dose-response analysis for radiotherapy delivered to patients with intermediate-grade and large-cell immunoblastic lymphomas that have completely responded to CHOP-based induction chemotherapy.
International journal of radiation oncology, biology, physics 2001;49(1):17-22.
2000: Anas Younes; M Cristofanilli; Peter McLaughlin; Fredrick B Hagemeister; Donna Weber; Ofelia M Mesina; Fernando Cabanillas
Experience with 9-cis retinoic acid in patients with relapsed and refractory non-Hodgkin's lymphoma.
Leukemia & lymphoma 2000;40(1-2):79-85.
2000: Peter McLaughlin; Fredrick B Hagemeister; Maria A Rodriguez; Andreas H Sarris; O Pate; Anas Younes; Ming-Sheng Lee; Nam H Dang; Jorge Romaguera; Alejandro Preti; N McAda; Fernando Cabanillas
Safety of fludarabine, mitoxantrone, and dexamethasone combined with rituximab in the treatment of stage IV indolent lymphoma.
Seminars in oncology 2000;27(6 Suppl 12):37-41.
2000: Jose Rodriguez; Peter McLaughlin; Luis Fayad; M Santiago; Mark Hess; Maria A Rodriguez; Jorge Romaguera; Fredrick Hagemeister; Andrew Lamb; Fernando Cabanillas
Follicular large cell lymphoma: long-term follow-up of 62 patients treated between 1973-1981.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(12):1551-6.
2000: Pamela J Schlembach; Richard B Wilder; Susan L Tucker; Chul Ha; Maria A Rodriguez; Mark A Hess; Fernando Cabanillas; James D Cox
Impact of involved field radiotherapy after CHOP-based chemotherapy on stage III-IV, intermediate grade and large-cell immunoblastic lymphomas.
International journal of radiation oncology, biology, physics 2000;48(4):1107-10.
2000: Andreas H Sarris; A Psyrri; Fredrick Hagemeister; Jorge Romaguera; Peter McLaughlin; Maria A Rodriguez; CR Bachier; Anas Younes; Ofelia M Mesina; M Oholendt; L Jeffrey Medeiros; Barry Samuels; Laurel M Adams; Fernando Cabanillas
Infusional vinorelbine in relapsed or refractory lymphomas.
Leukemia & lymphoma 2000;39(3-4):291-9.
2000: Paolo Anderlini; Sergio Giralt; Borje Andersson; Naoto T Ueno; Issa Khouri; Sandra Acholonu; Agueda Cohen; Martin Körbling; J Manning; Jorge Romaguera; Andreas H Sarris; Fredrick Hagemeister; Peter McLaughlin; Fernando Cabanillas; Richard E Champlin
Allogeneic stem cell transplantation with fludarabine-based, less intensive conditioning regimens as adoptive immunotherapy in advanced Hodgkin's disease.
Bone marrow transplantation 2000;26(6):615-20.
2000: Jose Rodriguez; Jorge Romaguera; J Manning; Nelson G Ordonez; Chul Ha; Farhad Ravandi; Fernando Cabanillas
Nasal-type T/NK lymphomas: a clinicopathologic study of 13 cases.
Leukemia & lymphoma 2000;39(1-2):139-44.
2000: Jorge Romaguera; Issa F Khouri; Hagop M Kantarjian; Fredrick B Hagemeister; Maria A Rodriguez; Peter McLaughlin; Andreas H Sarris; Anas Younes; Jose Rodriguez; Fernando Cabanillas
Untreated aggressive mantle cell lymphoma: results with intensive chemotherapy without stem cell transplant in elderly patients.
Leukemia & lymphoma 2000;39(1-2):77-85.
2000: Zhongxing Liao; Chul Ha; Peter McLaughlin; JT Manning; Mark Hess; Fernando Cabanillas; James D Cox
Mucosa-associated lymphoid tissue lymphoma with initial supradiaphragmatic presentation: natural history and patterns of disease progression.
International journal of radiation oncology, biology, physics 2000;48(2):399-403.
2000: Ruth Katz; Nancy P Caraway; Jun Gu; Feng Jiang; L A Pasco-Miller; Armand B. Glassman; Rajyalakshmi Luthra; Kimberly J Hayes; Jorge Romaguera; Fernando Cabanillas; L Jeffrey Medeiros
Detection of chromosome 11q13 breakpoints by interphase fluorescence in situ hybridization. A useful ancillary method for the diagnosis of mantle cell lymphoma.
American journal of clinical pathology 2000;114(2):248-57.
2000: Linh N Nguyen; Chul Ha; Mark Hess; Jorge Romaguera; JT Manning; Fernando Cabanillas; James D Cox
The outcome of combined-modality treatments for stage I and II primary large B-cell lymphoma of the mediastinum.
International journal of radiation oncology, biology, physics 2000;47(5):1281-5.
2000: S Verstovsek; Fernando Cabanillas; Nam H Dang
CD26 in T-cell lymphomas: a potential clinical role?
Oncology (Williston Park, N.Y.) 2000;14(6 Suppl 2):17-23.
2000: Fernando Cabanillas
Purine nucleoside analogs in indolent non-Hodgkin's lymphoma.
Oncology (Williston Park, N.Y.) 2000;14(6 Suppl 2):13-5.
2000: A López-Guillermo; Fernando Cabanillas; Peter McLaughlin; T Smith; Fredrick Hagemeister; MA Rodríguez; Jorge Romaguera; Anas Younes; Andreas H Sarris; H Alejandro Preti; WC Pugh; Ming-Sheng Lee
Molecular response assessed by PCR is the most important factor predicting failure-free survival in indolent follicular lymphoma: update of the MDACC series.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11 Suppl 1():137-40.
2000: Andreas H Sarris; Fredrick Hagemeister; Jorge Romaguera; Maria A Rodriguez; Peter McLaughlin; Apostolia-Maria Tsimberidou; L Jeffrey Medeiros; Barry Samuels; O Pate; M Oholendt; Andrew Lamb; C Burge; Fernando Cabanillas
Liposomal vincristine in relapsed non-Hodgkin's lymphomas: early results of an ongoing phase II trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(1):69-72.
1999: Chul Ha; Susan L Tucker; Angel I Blanco; Fernando Cabanillas; James D Cox
Salvage central lymphatic irradiation in follicular lymphomas following failure of chemotherapy: a feasibility study.
International journal of radiation oncology, biology, physics 1999;45(5):1207-12.
1999: Issa F Khouri; Ming-Sheng Lee; Jorge Romaguera; N Mirza; Andrew Lamb; Martin Korbling; Maher Albitar; Sergio Giralt; Barry Samuels; Paolo Anderlini; Jose Rodriguez; B von Wolff; James L Gajewski; Fernando Cabanillas; Richard Champlin
Allogeneic hematopoietic transplantation for mantle-cell lymphoma: molecular remissions and evidence of graft-versus-malignancy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(11):1293-9.
1999: Michele L Donato; Richard E Champlin; Koen van Besien; Martin Korbling; Fernando Cabanillas; Paolo Anderlini; J G Gajewski; Jo Lauppe; April Durett; Borje Andersson; Sergio Giralt; Issa Khouri; Fredrick Hagemeister; Jorge Romaguera; Andreas H Sarris; Peter McLaughlin; Anas Younes; Cindy Ippoliti; D A Blamble; Jeane Hester; Adrian Gee; Maria A Rodriguez
Intensive dose ifosfamide and etoposide with G-CSF for stem cell mobilization in patients with non-Hodgkin's lymphoma.
Leukemia & lymphoma 1999;35(3-4):317-24.
1999: Fernando Cabanillas
The role of topoisomerase-I inhibitors in the treatment of non-Hodgkin's lymphoma.
Seminars in hematology 1999;36(4 Suppl 8):11-5.
1999: Rajyalakshmi Luthra; Andreas H Sarris; Seema Hai; A V Paladugu; Jorge Romaguera; Fernando Cabanillas; L Jeffrey Medeiros
Real-time 5'-->3' exonuclease-based PCR assay for detection of the t(11;14)(q13;q32).
American journal of clinical pathology 1999;112(4):524-30.
1999: Deborah A Thomas; Jorge Cortes; Susan O'Brien; Sherry Pierce; Stefan Faderl; Maher Albitar; Fredrick B Hagemeister; Fernando Cabanillas; S Murphy; Michael J Keating; Andrew Lamb
Hyper-CVAD program in Burkitt's-type adult acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(8):2461-70.
1999: JP Ayoub; J L Palmer; Yang Huh; Fernando Cabanillas; Anas Younes
Therapeutic and prognostic implications of peripheral blood lymphopenia in patients with Hodgkin's disease.
Leukemia & lymphoma 1999;34(5-6):519-27.
1999: G Steinbach; R Ford; GA Glober; Dory A Sample; Fredrick B Hagemeister; Patrick M Lynch; P W McLaughlin; M A Rodriguez; Jorge Romaguera; Andreas H Sarris; Anas Younes; R Luthra; JT Manning; C M Johnson; Sandeep Lahoti; Y Shen; J E Lee; RJ Winn; Robert Genta; D Y Graham; Fernando Cabanillas
Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial.
Annals of internal medicine 1999;131(2):88-95.
1999: Jose Rodriguez; Maria A Rodriguez; Luis Fayad; Peter McLaughlin; F Swan; Andreas H Sarris; Jorge Romaguera; Borje Andersson; Fernando Cabanillas; Fredrick B Hagemeister
ASHAP: a regimen for cytoreduction of refractory or recurrent Hodgkin's disease.
Blood 1999;93(11):3632-6.
1999: A López-Guillermo; Fernando Cabanillas; Timothy J McDonnell; Peter McLaughlin; T Smith; WC Pugh; Fredrick Hagemeister; MA Rodríguez; Jorge Romaguera; Anas Younes; Andreas H Sarris; H Alejandro Preti; Ming-Sheng Lee
Correlation of bcl-2 rearrangement with clinical characteristics and outcome in indolent follicular lymphoma.
Blood 1999;93(9):3081-7.
1999: Andreas H Sarris; Kay-Oliver Kliche; P Pethambaram; Alejandro Preti; S Tucker; CM Jackow; O Messina; WC Pugh; Fredrick B Hagemeister; Peter McLaughlin; Maria A Rodriguez; Jorge Romaguera; Herbert A Fritsche; T Witzig; Madeleine Duvic; Michael Andreeff; Fernando Cabanillas
Interleukin-10 levels are often elevated in serum of adults with Hodgkin's disease and are associated with inferior failure-free survival.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(4):433-40.
1999: MD Logsdon; Raymond E Meyn; PC Besa; WC Pugh; L Clifton Stephens; LJ Peters; Luka Milas; James D Cox; Fernando Cabanillas; Shawn Brisbay; M Andersen; Timothy J McDonnell
Apoptosis and the Bcl-2 gene family -- patterns of expression and prognostic value in stage I and II follicular center lymphoma.
International journal of radiation oncology, biology, physics 1999;44(1):19-29.
1999: Chul Ha; M J Cho; Pamela K Allen; Lillian M Fuller; Fernando Cabanillas; James D Cox
Primary non-Hodgkin lymphoma of the small bowel.
Radiology 1999;211(1):183-7.
1999: Jose Rodriguez; Peter McLaughlin; Fredrick B Hagemeister; Luis Fayad; Maria A Rodriguez; M Santiago; Mark Hess; Jorge Romaguera; Fernando Cabanillas
Follicular large cell lymphoma: an aggressive lymphoma that often presents with favorable prognostic features.
Blood 1999;93(7):2202-7.
1999: Y K Oh; Chul Ha; B I Samuels; Fernando Cabanillas; Mark A Hess; James D Cox
Stages I-III follicular lymphoma: role of CT of the abdomen and pelvis in follow-up studies.
Radiology 1999;210(2):483-6.
1999: Chul Ha; Vivek Kavadi; M A Dimopoulos; Fredrick B Hagemeister; B M Osborne; Lillian M Fuller; T L Smith; Mark A Hess; P W McLaughlin; Fernando Cabanillas; James D Cox
Hodgkin's disease with lymphocyte predominance: long-term results based on current histopathologic criteria.
International journal of radiation oncology, biology, physics 1999;43(2):329-34.
1999: Jorge Romaguera; Maria A Rodriguez; Fredrick B Hagemeister; Peter McLaughlin; J Rodriguez; A Preti; Anas Younes; Andreas H Sarris; Fernando Cabanillas
Phase II study of paclitaxel in combination with mitoxantrone and ifosfamide/mesna for patients with relapsed or refractory non-Hodgkin's lymphoma after failure to cytarabine/cisplatin combination.
Investigational new drugs 1999;17(2):187-92.
1999: CR Bachier; R E Giles; D Ellerson; EG Hanania; F Garcia Sanchez; Michael Andreeff; Fernando Cabanillas; Richard Champlin; R Choudhury; R Berenson; S Heimfeld; Albert Deisseroth
Hematopoietic retroviral gene marking in patients with follicular non-Hodgkin's lymphoma.
Leukemia & lymphoma 1999;32(3-4):279-88.
1998: Jorge Romaguera; Fredrick B Hagemeister; Peter McLaughlin; Maria A Rodriguez; CR Bachier; H Alejandro Preti; Andreas H Sarris; Donna Weber; Anas Younes; Fernando Cabanillas
Ninety-six-hour paclitaxel infusion with mitoxantrone and ifosfamide/mesna and consolidation with ESHAP for refractory and relapsed non-Hodgkin's lymphoma.
Leukemia & lymphoma 1998;32(1-2):97-106.
1998: Anas Younes; Jorge Romaguera; Ofelia M Mesina; Fredrick Hagemeister; Andreas H Sarris; Maria A Rodriguez; Peter McLaughlin; H Alejandro Preti; CR Bachier; Fernando Cabanillas
Paclitaxel plus high-dose cyclophosphamide with G-CSF support in patients with relapsed and refractory aggressive non-Hodgkin's lymphoma.
British journal of haematology 1998;103(3):678-83.
1998: Issa F Khouri; Jorge Romaguera; Andrew Lamb; J Lynn Palmer; WC Pugh; Martin Korbling; Fredrick Hagemeister; Barry Samuels; A Rodriguez; Sergio Giralt; Anas Younes; Donna Przepiorka; David F Claxton; Fernando Cabanillas; Richard Champlin
Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(12):3803-9.
1998: Katharina Clodi; Z Asgary; Shourong Zhao; Kay-Oliver Kliche; Fernando Cabanillas; Michael Andreeff; Anas Younes
Coexpression of CD40 and CD40 ligand in B-cell lymphoma cells.
British journal of haematology 1998;103(1):270-5.
1998: Katharina Clodi; Virginia Snell; Shourong Zhao; Fernando Cabanillas; Michael Andreeff; Anas Younes
Unbalanced expression of Fas and CD40 in mantle cell lymphoma.
British journal of haematology 1998;103(1):217-9.
1998: Maria T Vlachaki; Chul Ha; Fredrick B Hagemeister; Lillian M Fuller; Maria A Rodriguez; Mark A Hess; Susan L Tucker; Fernando Cabanillas; James D Cox
Stage I Hodgkin disease: radiation therapy and chemotherapy at the University of Texas M. D. Anderson Cancer Center, 1996-1997.
Radiology 1998;208(3):739-47.
1998: Luis Fayad; Fernando Cabanillas; Moshe Talpaz; Peter McLaughlin; Razelle Kurzrock
High serum interleukin-6 levels correlate with a shorter failure-free survival in indolent lymphoma.
Leukemia & lymphoma 1998;30(5-6):563-71.
1998: Chul Ha; P Dubey; Lav K Goyal; M Hess; Fernando Cabanillas; James D Cox
Localized primary non-Hodgkin lymphoma of the breast.
American journal of clinical oncology 1998;21(4):376-80.
1998: Peter McLaughlin; Antonio J Grillo-López; B K Link; Ronald Levy; Myron S Czuczman; M E Williams; M R Heyman; I Bence-Bruckler; Christine White; Fernando Cabanillas; V Jain; A D Ho; J Lister; K Wey; D Shen; BK Dallaire
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(8):2825-33.
1998: Zhongxing Liao; Chul Ha; Lillian M Fuller; Fredrick B Hagemeister; Fernando Cabanillas; Susan L Tucker; Mark A Hess; James D Cox
Subdiaphragmatic stage I & II Hodgkin's disease: long-term follow-up and prognostic factors.
International journal of radiation oncology, biology, physics 1998;41(5):1047-56.
1998: Mar Tormo; Ana M Tari; Timothy J McDonnell; Fernando Cabanillas; Javier Garcia-Conde; Gabriel Lopez-Berestein
Apoptotic induction in transformed follicular lymphoma cells by Bcl-2 downregulation.
Leukemia & lymphoma 1998;30(3-4):367-79.
1998: Rajyalakshmi Luthra; JA McBride; Fernando Cabanillas; Andreas H Sarris
Novel 5' exonuclease-based real-time PCR assay for the detection of t(14;18)(q32;q21) in patients with follicular lymphoma.
The American journal of pathology 1998;153(1):63-8.
1998: Moshe H Maor; LB North; Fernando Cabanillas; A L Ames; Mark A Hess; James D Cox
Outcomes of high-dose unilateral kidney irradiation in patients with gastric lymphoma.
International journal of radiation oncology, biology, physics 1998;41(3):647-50.
1998: Fernando Cabanillas; J Rodriguez-Diaz Pavón; Fredrick B Hagemeister; Peter McLaughlin; Maria A Rodriguez; Jorge Romaguera; K Dong; T Moon
Alternating triple therapy for the treatment of intermediate grade and immunoblastic lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(5):511-8.
1998: Andreas H Sarris; Rajyalakshmi Luthra; Fernando Cabanillas; SW Morris; WC Pugh
Genomic DNA amplification and the detection of t(2;5)(p23;q35) in lymphoid neoplasms.
Leukemia & lymphoma 1998;29(5-6):507-14.
1998: J Herrada; Fernando Cabanillas; L Rice; J Manning; WC Pugh
The clinical behavior of localized and multicentric Castleman disease.
Annals of internal medicine 1998;128(8):657-62.
1998: A López-Guillermo; Fernando Cabanillas; Peter McLaughlin; T Smith; Fredrick Hagemeister; MA Rodríguez; Jorge Romaguera; Anas Younes; Andreas H Sarris; H Alejandro Preti; WC Pugh; Ming-Sheng Lee
The clinical significance of molecular response in indolent follicular lymphomas.
Blood 1998;91(8):2955-60.
1998: Danai D Daliani; R A Ulmer; CM Jackow; WC Pugh; B Gansbacher; Fernando Cabanillas; Madeleine Duvic; Andreas H Sarris
Tumor necrosis factor-alpha and interferon-gamma, but not HTLV-I tax, are likely factors in the epidermotropism of cutaneous T-cell lymphoma via induction of interferon-inducible protein-10.
Leukemia & lymphoma 1998;29(3-4):315-28.
1998: Jonathan H Hughes; Ruth Katz; G A Fonseca; Fernando Cabanillas
Fine-needle aspiration cytology of mediastinal non-Hodgkin's nonlymphoblastic lymphoma.
Cancer 1998;84(1):26-35.
1998: Koen van Besien; Chul Ha; S Murphy; Peter McLaughlin; A Rodriguez; K Amin; A Forman; Jorge Romaguera; Fredrick Hagemeister; Anas Younes; CR Bachier; Andreas H Sarris; K S Sobocinski; James D Cox; Fernando Cabanillas
Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma.
Blood 1998;91(4):1178-84.
1998: Lillian M Fuller; Nadeem Q Mirza; J Lynn Palmer; B R Davis; Chul Ha; Maria A Rodriguez; Fredrick B Hagemeister; Fernando Cabanillas; Peter McLaughlin; J J Butler; LB North; R G Martin
Hodgkin's disease: correlation of clinical characteristics with probabilities for negative lymphangiogram vs. negative laparotomy findings in patients with Stage I supradiaphragmatic presentations vs. those in patients with Stage II.
International journal of radiation oncology, biology, physics 1998;40(2):377-86.
1998: Rajyalakshmi Luthra; WC Pugh; M Waasdorp; W Morris; Fernando Cabanillas; P K Chan; Andreas H Sarris
Mapping of genomic t(2;5)(p23;q35) break points in patients with anaplastic large cell lymphoma by sequencing long-range PCR products.
Hematopathology and molecular hematology 1998;11(3-4):173-83.
1998: Jorge Romaguera; J Rodríguez Díaz-Pavon; L Carías; Fredrick B Hagemeister; Peter McLaughlin; M A Rodríguez; Andreas H Sarris; Anas Younes; Alejandro Preti; CR Bachier; E Llerena; Fernando Cabanillas
Use of the international prognostic index and the tumor score to detect poor-risk patients with primary mediastinal large B-cell lymphoma: a study of 37 previously untreated patients.
Leukemia & lymphoma 1998;28(3-4):295-306.
1998: Uday Popat; D Przepiork; Richard Champlin; WC Pugh; K Amin; RC Mehra; J Rodriguez; Sergio Giralt; Jorge Romaguera; A Rodriguez; Alejandro Preti; Borje Andersson; Issa Khouri; David F Claxton; Marcos De Lima; Michele Donato; Paolo Anderlini; James L Gajewski; Fernando Cabanillas; Koen van Besien
High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: mediastinal localization predicts for a favorable outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(1):63-9.
1997: Fernando Cabanillas
Can we cure indolent lymphomas?
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(12 Pt 2):2655-9.
1997: Michael J Keating; Peter McLaughlin; Fernando Cabanillas
Low-grade non-Hodgkin's lymphoma--development of a new effective combination regimen (fludarabine, mitoxantrone and dexamethasone; FND).
European journal of cancer care 1997;6(4 Suppl):21-6.
1997: Virginia Snell; Katharina Clodi; Shourong Zhao; R Goodwin; EK Thomas; S W Morris; Marshall E Kadin; Fernando Cabanillas; Michael Andreeff; Anas Younes
Activity of TNF-related apoptosis-inducing ligand (TRAIL) in haematological malignancies.
British journal of haematology 1997;99(3):618-24.
1997: Marvin L Meistrich; Gene Wilson; K Mathur; Lillian M Fuller; Maria A Rodriguez; Peter McLaughlin; Jorge Romaguera; Fernando Cabanillas; Chul Ha; Larry I Lipshultz; Fredrick B Hagemeister
Rapid recovery of spermatogenesis after mitoxantrone, vincristine, vinblastine, and prednisone chemotherapy for Hodgkin's disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(12):3488-95.
1997: R Munker; Anas Younes; Fernando Cabanillas; Michael Andreeff
Soluble CD95 in the serum of patients with low and intermediate grade malignant lymphomas: absence of prognostic correlations.
Leukemia & lymphoma 1997;27(5-6):517-21.
1997: Anas Younes; U Consoli; Virginia Snell; Katharina Clodi; Kay-Oliver Kliche; J Lynn Palmer; H J Gruss; R Armitage; EK Thomas; Fernando Cabanillas; Michael Andreeff
CD30 ligand in lymphoma patients with CD30+ tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(11):3355-62.
1997: M J Cho; Chul Ha; Pamela K Allen; Lillian M Fuller; Fernando Cabanillas; James D Cox
Primary non-Hodgkin lymphoma of the large bowel.
Radiology 1997;205(2):535-9.
1997: A Sundaresan; K Claypool; Kapil Mehta; Gabriel Lopez-Berestein; Fernando Cabanillas; Richard J Ford
Retinoid-mediated inhibition of cell growth with stimulation of apoptosis in aggressive B-cell lymphomas.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1997;8(10):1071-82.
1997: EJ Rodriguez-Monge; Fernando Cabanillas
Long-term follow-up of platinum-based lymphoma salvage regimens. The M.D. Anderson Cancer Center experience.
Hematology/oncology clinics of North America 1997;11(5):937-47.
1997: Maria T Vlachaki; Chul Ha; Fredrick B Hagemeister; Lillian M Fuller; Maria A Rodriguez; PC Besa; Mark A Hess; B Brown; Fernando Cabanillas; James D Cox
Long-term outcome of treatment for Ann Arbor stage 1 Hodgkin's disease: patterns of failure, late toxicity and second malignancies.
International journal of radiation oncology, biology, physics 1997;39(3):609-16.
1997: Katharina Clodi; Anas Younes; AM Goodacre; M Roberts; J Palmer; Mamoun Younes; Fernando Cabanillas; Michael Andreeff
Analysis of p53 gene deletions in patients with non-Hodgkin's lymphoma by dual-colour fluorescence in-situ hybridization.
British journal of haematology 1997;98(4):913-21.
1997: Koen van Besien; Peter F Thall; Martin Korbling; WC Pugh; Issa Khouri; RC Mehra; Sergio Giralt; Paolo Anderlini; K Amin; N Mirza; D Seong; James L Gajewski; Jeane Hester; Borje Andersson; Fernando Cabanillas; Richard Champlin; Donna Przepiorka
Allogeneic transplantation for recurrent or refractory non-Hodgkin's lymphoma with poor prognostic features after conditioning with thiotepa, busulfan, and cyclophosphamide: experience in 44 consecutive patients.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1997;3(3):150-6.
1997: H Alejandro Preti; Fernando Cabanillas; Moshe Talpaz; S L Tucker; J F Seymour; Razelle Kurzrock
Prognostic value of serum interleukin-6 in diffuse large-cell lymphoma.
Annals of internal medicine 1997;127(3):186-94.
1997: MD Logsdon; Chul Ha; Vivek Kavadi; Fernando Cabanillas; Mark A Hess; James D Cox
Lymphoma of the nasal cavity and paranasal sinuses: improved outcome and altered prognostic factors with combined modality therapy.
Cancer 1997;80(3):477-88.
1997: Anas Younes; Maria A Rodriguez; Peter McLaughlin; LB North; Andreas H Sarris; O Pate; Fredrick B Hagemeister; Jorge Romaguera; Alejandro Preti; CR Bachier; Fernando Cabanillas
Phase I study of fludarabine and paclitaxel for the treatment of low-grade non-Hodgkin's lymphoma.
Leukemia & lymphoma 1997;26(1-2):77-82.
1997: Andreas H Sarris; V Papadimitrakopoulou; Meletios A Dimopoulos; T Smith; WC Pugh; Chul Ha; Peter McLaughlin; David L Callender; J Cox; Fernando Cabanillas
Primary parotid lymphoma: the effect of International Prognostic Index on outcome.
Leukemia & lymphoma 1997;26(1-2):49-56.
1997: Maria T Vlachaki; Fredrick B Hagemeister; Lillian M Fuller; PC Besa; Mark A Hess; B Brown; Fernando Cabanillas; James D Cox
Long-term outcome of treatment for Ann Arbor Stage I Hodgkin's disease: prognostic factors for survival and freedom from progression.
International journal of radiation oncology, biology, physics 1997;38(3):593-9.
1997: JP Ayoub; LB North; J Greer; Fernando Cabanillas; Anas Younes
Pulmonary changes in patients with lymphoma who receive paclitaxel.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(6):2476.
1997: Alejandro Majlis; WC Pugh; Maria A Rodriguez; William F Benedict; Fernando Cabanillas
Mantle cell lymphoma: correlation of clinical outcome and biologic features with three histologic variants.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(4):1664-71.
1997: Rajyalakshmi Luthra; JA McBride; Seema Hai; Fernando Cabanillas; WC Pugh
The application of fluorescence-based PCR and PCR-SSCP to monitor the clonal relationship of cells bearing the t(14;18)(q32;q21) in sequential biopsy specimens from patients with follicle center cell lymphoma.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 1997;6(2):71-7.
1997: P Dubey; Chul Ha; PC Besa; L Fuller; Fernando Cabanillas; J Murray; Mark A Hess; James D Cox
Localized primary malignant lymphoma of bone.
International journal of radiation oncology, biology, physics 1997;37(5):1087-93.
1997: Meletios A Dimopoulos; Danai D Daliani; WC Pugh; David M Gershenson; Fernando Cabanillas; Andreas H Sarris
Primary ovarian non-Hodgkin's lymphoma: outcome after treatment with combination chemotherapy.
Gynecologic oncology 1997;64(3):446-50.
1997: Chul Ha; Fernando Cabanillas; Ming-Sheng Lee; PC Besa; Peter McLaughlin; James D Cox
Serial determination of the bcl-2 gene in the bone marrow and peripheral blood after central lymphatic irradiation for stages I-III follicular lymphoma: a preliminary report.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(2):215-9.
1997: Andreas H Sarris; Danai D Daliani; R Ulmer; M Crow; H E Broxmeyer; M Reiss; N Karasavvas; Andrew D Zelenetz; WC Pugh; Fernando Cabanillas; Albert Deisseroth; Madeleine Duvic
Interferon-inducible protein 10 as a possible factor in the pathogenesis of cutaneous T-cell lymphomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(2):169-77.
1997: Anas Younes; JP Ayoub; Andreas H Sarris; Fredrick Hagemeister; LB North; O Pate; Peter McLaughlin; Maria A Rodriguez; Jorge Romaguera; R Kurzrock; Alejandro Preti; CR Bachier; T Smith; Fernando Cabanillas
Paclitaxel activity for the treatment of non-Hodgkin's lymphoma: final report of a phase II trial.
British journal of haematology 1997;96(2):328-32.
1997: Anas Younes; Shourong Zhao; X Zhang; Virginia Snell; Katharina Clodi; Kay-Oliver Kliche; E Thomas; Fernando Cabanillas; Michael Andreeff
CD30-ligand and CD40-ligand expression in lymph nodes involved with Hodgkin's disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8 Suppl 2():97-100.
1997: Andreas H Sarris; Rajyalakshmi Luthra; V Papadimitracopoulou; M Waasdorp; Meletios A Dimopoulos; JA McBride; Fernando Cabanillas; Madeleine Duvic; A Deisseroth; SW Morris; WC Pugh
Long-range amplification of genomic DNA detects the t(2;5)(p23;q35) in anaplastic large-cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8 Suppl 2():59-63.
1997: Anas Younes; JP Ayoub; Andreas H Sarris; LB North; O Pate; Peter McLaughlin; Maria A Rodriguez; Jorge Romaguera; Fredrick Hagemeister; CR Bachier; Alejandro Preti; Fernando Cabanillas
Paclitaxel (Taxol) for the treatment of lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8 Suppl 1():129-31.
1997: J Herrada; D K Phillips; Adelaide A Hebert; Fernando Cabanillas; R E Jordon
A progressive blistering eruption in a patient with lymphoma. Paraneoplastic pemphigus.
Archives of dermatology 1997;133(1):97, 100-1.
1996: Andreas H Sarris; Danai D Daliani; R Ulmer; M Crow; H E Broxmeyer; WC Pugh; M Reiss; Fernando Cabanillas; Albert Deisseroth; Madeleine Duvic
Interferon-inducible protein-10 and the pathogenesis of cutaneous T-cell lymphomas.
Leukemia & lymphoma 1996;24(1-2):103-10.
1996: Anas Younes; Fernando Cabanillas; P W McLaughlin; F B Hagemeister; Charles Michael Farber; Andreas H Sarris; O Pate; J Myers; Carol S Portlock
Preliminary experience with paclitaxel for the treatment of relapsed and refractory Hodgkin's disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(10):1083-5.
1996: Jorge Romaguera; S Meilus; Jose Rodriguez; T Brooks; Nelson G Ordonez; Fernando Cabanillas
Endocrine characterization of primary mediastinal lymphoma.
Leukemia & lymphoma 1996;23(5-6):613-5.
1996: Luis Fayad; LE Robertson; Susan O'Brien; J T Manning; S Wright; F Hagemeister; Fernando Cabanillas; Michael J Keating
Hodgkin's disease variant of Richter's syndrome: experience at a single institution.
Leukemia & lymphoma 1996;23(3-4):333-7.
1996: Andreas H Sarris; Rajyalakshmi Luthra; V Papadimitracopoulou; M Waasdorp; Meletios A Dimopoulos; JA McBride; Fernando Cabanillas; Madeleine Duvic; Albert Deisseroth; S W Morris; WC Pugh
Amplification of genomic DNA demonstrates the presence of the t(2;5) (p23;q35) in anaplastic large cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis.
Blood 1996;88(5):1771-9.
1996: Anas Younes; U Consoli; Shourong Zhao; Virginia Snell; E Thomas; H J Gruss; Fernando Cabanillas; Michael Andreeff
CD30 ligand is expressed on resting normal and malignant human B lymphocytes.
British journal of haematology 1996;93(3):569-71.
1996: Madeleine Duvic; N A Lemak; J R Redman; Patricia J Eifel; Susan L Tucker; Fernando Cabanillas; Razelle Kurzrock
Combined modality therapy for cutaneous T-cell lymphoma.
Journal of the American Academy of Dermatology 1996;34(6):1022-9.
1996: Elihu Estey; Peter F Thall; Kapil Mehta; M Rosenblum; T Brewer; V Simmons; Fernando Cabanillas; Razelle Kurzrock; Gabriel Lopez-Berestein
Alterations in tretinoin pharmacokinetics following administration of liposomal all-trans retinoic acid.
Blood 1996;87(9):3650-4.
1996: Peter McLaughlin; F B Hagemeister; Jorge Romaguera; Andreas H Sarris; O Pate; Anas Younes; F Swan; Michael Keating; Fernando Cabanillas
Fludarabine, mitoxantrone, and dexamethasone: an effective new regimen for indolent lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(4):1262-8.
1996: Anas Younes; Andreas H Sarris; U Consoli; A Rodriguez; Peter McLaughlin; Y Huh; S Starry; Fernando Cabanillas; Michael Andreeff
A pilot study of high-dose interleukin-3 treatment of relapsed follicular small cleaved-cell lymphoma: hematologic, immunologic, and clinical results.
Blood 1996;87(5):1698-703.
1996: Koen van Besien; RC Mehra; Sergio Giralt; Hagop M Kantarjian; WC Pugh; I F Khouri; Y Moon; P Williams; Borje S Andersson; Donna Przepiorka; Philip L McCarthy; James L Gajewski; Albert Deisseroth; Fernando Cabanillas; Richard Champlin
Allogeneic bone marrow transplantation for poor-prognosis lymphoma: response, toxicity and survival depend on disease histology.
The American journal of medicine 1996;100(3):299-307.
1996: J F Seymour; Peter McLaughlin; Lillian M Fuller; F B Hagemeister; M Hess; F Swan; Jorge Romaguera; Maria A Rodriguez; PC Besa; J Cox; Fernando Cabanillas
High rate of prolonged remissions following combined modality therapy for patients with localized low-grade lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(2):157-63.
1996: Anas Younes; JP Ayoub; F B Hagemeister; Peter McLaughlin; Andreas H Sarris; Maria A Rodriguez; F Swan; Jorge Romaguera; J Martin; Fernando Cabanillas
No effect of 96-hour paclitaxel infusion in patients with relapsed non-Hodgkin's lymphoma refractory to a 3-hour infusion schedule.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(2):543-8.
1996: JA McBride; Jose Rodriguez; Rajyalakshmi Luthra; Nelson G Ordóñez; Fernando Cabanillas; WC Pugh
T-cell-rich B large-cell lymphoma simulating lymphocyte-rich Hodgkin's disease.
The American journal of surgical pathology 1996;20(2):193-201.
1996: Andreas H Sarris; Anas Younes; Peter McLaughlin; D Moore; F Hagemeister; F Swan; Maria A Rodriguez; Jorge Romaguera; LB North; P Mansfield; D Callendar; O Mesina; Fernando Cabanillas
Cyclosporin A does not reverse clinical resistance to paclitaxel in patients with relapsed non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(1):233-9.
1995: Jorge Romaguera; J Garcia-Foncillas; Fernando Cabanillas
16-year experience at M. D. Anderson Cancer Center with primary Ki-1 (CD30) antigen expression and anaplastic morphology in adult patients with diffuse large cell lymphoma.
Leukemia & lymphoma 1995;20(1-2):97-102.
1995: R Ford; Archito Tamayo; B Martin; K Niu; K Claypool; Fernando Cabanillas; J Ambrus
Identification of B-cell growth factors (interleukin-14; high molecular weight-B-cell growth factors) in effusion fluids from patients with aggressive B-cell lymphomas.
Blood 1995;86(1):283-93.
1995: W F Symmans; Ruth Katz; N G Ordoñez; H Dalton; Jorge Romaguera; Fernando Cabanillas
Transformation of follicular lymphoma. Expression of p53 and bcl-2 oncoprotein, apoptosis and cell proliferation.
Acta cytologica 1995;39(4):673-82.
1995: David Jendiroba; Anas Younes; R Katz; D Hill; Fernando Cabanillas; Michael Andreeff
Chromosome 17 numerical abnormalities in 55 patients with non-Hodgkin's lymphoma: a fluorescence in situ hybridization study.
Leukemia 1995;9(7):1144-6.
1995: Anas Younes; David Jendiroba; R Katz; D Hill; Fernando Cabanillas; Michael Andreeff
Chromosome X numerical abnormalities in patients with non-Hodgkin's lymphoma. A study of 59 patients using fluorescence in situ hybridization.
Cancer genetics and cytogenetics 1995;82(1):23-9.
1995: Andreas H Sarris; Meletios A Dimopoulos; WC Pugh; Fernando Cabanillas
Primary lymphoma of the prostate: good outcome with doxorubicin-based combination chemotherapy.
The Journal of urology 1995;153(6):1852-4.
1995: N Touroutoglou; Meletios A Dimopoulos; Anas Younes; M Hess; WC Pugh; J Cox; Fernando Cabanillas; Andreas H Sarris
Testicular lymphoma: late relapses and poor outcome despite doxorubicin-based therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(6):1361-7.
1995: Anas Younes; Shourong Zhao; David Jendiroba; H D Kleine; Fernando Cabanillas; Michael Andreeff
Decreased expression of the deleted in colorectal carcinoma gene in non-Hodgkin's lymphoma.
Blood 1995;85(10):2813-6.
1995: E L Stroh; PC Besa; James D Cox; Lillian M Fuller; Fernando Cabanillas
Treatment of patients with lymphomas of the uterus or cervix with combination chemotherapy and radiation therapy.
Cancer 1995;75(9):2392-9.
1995: Andreas H Sarris; Alejandro Majlis; Meletios A Dimopoulos; Anas Younes; F Swann; Maria A Rodriguez; Peter McLaughlin; Fernando Cabanillas
Rising serum lactate dehydrogenase often caused by granulocyte-or Granulocyte-macrophage colony stimulating factor and not tumor progression in patients with lymphoma or myeloma.
Leukemia & lymphoma 1995;17(5-6):473-7.
1995: J E Cortes; Moshe Talpaz; Fernando Cabanillas; J F Seymour; Razelle Kurzrock
Serum levels of interleukin-10 in patients with diffuse large cell lymphoma: lack of correlation with prognosis.
Blood 1995;85(9):2516-20.
1995: J Herrada; Fernando Cabanillas
Multicentric Castleman's disease.
American journal of clinical oncology 1995;18(2):180-3.
1995: J F Seymour; Moshe Talpaz; Fernando Cabanillas; Meir Wetzler; Razelle Kurzrock
Serum interleukin-6 levels correlate with prognosis in diffuse large-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(3):575-82.
1995: J R Diaz-Pavon; WC Pugh; Fernando Cabanillas
Simultaneous presentation of hairy cell leukemia and follicular small cleaved cell lymphoma in a patient with previous diagnosis of renal cell carcinoma.
Hematological oncology 1995;13(2):63-7.
1995: Fernando Cabanillas; J Armitage; WC Pugh; D Weisenburger; Madeleine Duvic
Lymphomatoid papulosis: a T-cell dyscrasia with a propensity to transform into malignant lymphoma.
Annals of internal medicine 1995;122(3):210-7.
1995: D F Moore; F Swan; J Yau; Maria A Rodriguez; Peter McLaughlin; Andreas H Sarris; Jorge Romaguera; Anas Younes; F B Hagemeister; Fernando Cabanillas
Cyclosporin plus doxorubicin, vincristine and etoposide in the treatment of refractory non-Hodgkin's lymphoma: a phase II study.
Clinical oncology (Royal College of Radiologists (Great Britain)) 1995;7(5):300-3.
1995: J R Diaz-Pavon; Fernando Cabanillas; A Majlis; F B Hagemeister
Outcome of Hodgkin's disease in elderly patients.
Hematological oncology 1995;13(1):19-27.
1995: Lillian M Fuller; M J Krasin; W S Velasquez; Pamela K Allen; Peter McLaughlin; Maria A Rodriguez; F B Hagemeister; F Swan; Fernando Cabanillas; J L Palmer
Significance of tumor size and radiation dose to local control in stage I-III diffuse large cell lymphoma treated with CHOP-Bleo and radiation.
International journal of radiation oncology, biology, physics 1995;31(1):3-11.
1994: Meletios A Dimopoulos; Andrew Lamb; Donna Weber; Susan O'Brien; Elihu Estey; Kay Delasalle; E Rose; Fernando Cabanillas; Michael Keating; Raymond Alexanian
Primary therapy of Waldenström's macroglobulinemia with 2-chlorodeoxyadenosine.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(12):2694-8.
1994: Jose Rodriguez; WC Pugh; Jorge Romaguera; Rajyalakshmi Luthra; F B Hagemeister; Peter McLaughlin; Maria A Rodriguez; F Swan; Fernando Cabanillas
Primary mediastinal large cell lymphoma is characterized by an inverted pattern of large tumoral mass and low beta 2 microglobulin levels in serum and frequently elevated levels of serum lactate dehydrogenase.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(9):847-9.
1994: Anas Younes; David Jendiroba; H Engel; S Escudier; R Katz; M A Rodriguez; D Hill; Fernando Cabanillas; Michael Andreeff
High incidence of monosomy 18 in lymphoid malignancies that have bone marrow and peripheral blood involvement.
Cancer genetics and cytogenetics 1994;77(1):39-44.
1994: Jose Rodriguez; WC Pugh; Jorge Romaguera; Fernando Cabanillas
Primary mediastinal large cell lymphoma.
Hematological oncology 1994;12(4):175-84.
1994: W S Velasquez; Peter McLaughlin; S Tucker; F B Hagemeister; F Swan; Maria A Rodriguez; Jorge Romaguera; Edward B Rubenstein; Fernando Cabanillas
ESHAP--an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(6):1169-76.
1994: W S Velasquez; Peter McLaughlin; Lillian M Fuller; Pamela K Allen; Susan L Tucker; F Swan; Maria A Rodriguez; F B Hagemeister; Fernando Cabanillas
Intermediate-grade lymphomas treated with cyclophosphamide-doxorubicin- vincristine-prednisone-bleomycin alternated with cyclophosphamide-methotrexate-etoposide-dexamethasone. Application of prognostic models to data analysis.
Cancer 1994;73(9):2408-16.
1994: Jorge Romaguera; J T Manning; C S Tornos; Jose Rodriguez; T E Brooks; WC Pugh; Nelson G Ordonez; AM Goodacre; Fernando Cabanillas
Long-term prognostic importance of primary Ki-1 (CD30) antigen expression and anaplastic morphology in adult patients with diffuse large-cell lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(4):317-22.
1994: F B Hagemeister; R Purugganan; L Fuller; Peter McLaughlin; F Swan; Jorge Romaguera; M Rodriguez; Fernando Cabanillas
Treatment of early stages of Hodgkin's disease with novantrone, vincristine, vinblastine, prednisone, and radiotherapy.
Seminars in hematology 1994;31(2 Suppl 3):36-43.
1994: Fernando Cabanillas; Maria A Rodriguez
MINE-ESHAP salvage therapy for recurrent and refractory lymphomas.
Seminars in hematology 1994;31(2 Suppl 3):30.
1994: Peter McLaughlin; F B Hagemeister; F Swan; Fernando Cabanillas; O Pate; Jorge Romaguera; Maria A Rodriguez; J R Redman; Michael Keating
Phase I study of the combination of fludarabine, mitoxantrone, and dexamethasone in low-grade lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(3):575-9.
1994: Anas Younes; WC Pugh; AM Goodacre; R Katz; Maria A Rodriguez; D Hill; Fernando Cabanillas; Michael Andreeff
Polysomy of chromosome 12 in 60 patients with non-Hodgkin's lymphoma assessed by fluorescence in situ hybridization: differences between follicular and diffuse large cell lymphoma.
Genes, chromosomes & cancer 1994;9(3):161-7.
1994: Anas Younes; Johannes Drach; R Katz; David Jendiroba; M H Sabourian; Andreas H Sarris; F Swan; D Hill; Fernando Cabanillas; R Ford
Growth inhibition of follicular small-cleaved-cell lymphoma cells in short-term culture by interleukin-3.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(3):265-8.
1994: J F Seymour; Anas Younes; Fernando Cabanillas
Lymphomatous presentation of CD4+/CD8+ HTLV-1-related adult T-cell leukemia/lymphoma in an Iranian woman.
Leukemia & lymphoma 1994;12(5-6):471-6.
1994: Michael J Keating; Peter McLaughlin; William Plunkett; LE Robertson; Susan O'Brien; Varsha Gandhi; V Gregoire; L Yang; Fernando Cabanillas
Fludarabine--present status and future developments in chronic lymphocytic leukemia and lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5 Suppl 2():79-83.
1994: F B Hagemeister; R Purugganan; D A Podoloff; M Hess; Maria A Rodriguez; Peter McLaughlin; F Swan; Jorge Romaguera; Fernando Cabanillas
The gallium scan predicts relapse in patients with Hodgkin's disease treated with combined modality therapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5 Suppl 2():59-63.
1994: F B Hagemeister; R Khetan; P Allen; Peter McLaughlin; Maria A Rodriguez; F Swan; Jorge Romaguera; Fernando Cabanillas
Stage, serum LDH, and performance status predict disease progression and survival in HIV-associated lymphomas.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5 Suppl 2():41-6.
1994: Jorge Romaguera; Maria A Rodriguez; F B Hagemeister; Peter McLaughlin; F Swan; D F Moore; Andreas H Sarris; Anas Younes; D Hill; Fernando Cabanillas
A phase II trial of oral etoposide with mitoxantrone and ifosfamide/mesna consolidated with intravenous etoposide, methylprednisolone, high-dose arabinoside, and cisplatin as salvage therapy for relapsing and/or refractory lymphomas.
Investigational new drugs 1994;12(3):217-22.
1994: Michael J Keating; Susan O'Brien; LE Robertson; Andrew Lamb; Meletios A Dimopoulos; Peter McLaughlin; Fernando Cabanillas; V Gregoire; Y Y Li; Varsha Gandhi
The expanding role of fludarabine in hematologic malignancies.
Leukemia & lymphoma 1994;14 Suppl 2():11-6.
1994: Alejandro Preti; F B Hagemeister; Peter McLaughlin; F Swan; A Rodriguez; PC Besa; James D Cox; Pamela K Allen; Fernando Cabanillas
Hodgkin's disease with a mediastinal mass greater than 10 cm: results of four different treatment approaches.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5 Suppl 2():97-100.
1994: Peter McLaughlin; F B Hagemeister; F Swan; Fernando Cabanillas; Jorge Romaguera; Maria A Rodriguez; M S Lee; O Pate; Andreas H Sarris; Anas Younes
Intensive conventional-dose chemotherapy for stage IV low-grade lymphoma: high remission rates and reversion to negative of peripheral blood bcl-2 rearrangement.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5 Suppl 2():73-7.
1994: Michael J Keating; Susan O'Brien; William Plunkett; LE Robertson; Varsha Gandhi; Elihu Estey; Meletios A Dimopoulos; Fernando Cabanillas; A Kemena; Andrew Lamb
Fludarabine phosphate: a new active agent in hematologic malignancies.
Seminars in hematology 1994;31(1):28-39.
1993: LE Robertson; WC Pugh; Susan O'Brien; Andrew Lamb; Cheryl Hirsch-Ginsberg; A Cork; Peter McLaughlin; Fernando Cabanillas; Michael J Keating
Richter's syndrome: a report on 39 patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(10):1985-9.
1993: D F Moore; Fernando Cabanillas
What constitutes a "cure" in lymphoma?
Leukemia & lymphoma 1993;11(3-4):161-3.
1993: Michael J Keating; Susan O'Brien; LE Robertson; Andrew Lamb; Meletios A Dimopoulos; Peter McLaughlin; Fernando Cabanillas; V Gregoire; Li-Ying Yang; Varsha Gandhi
New initiatives with fludarabine monophosphate in hematologic malignancies.
Seminars in oncology 1993;20(5 Suppl 7):13-20.
1993: Jose Rodriguez; WC Pugh; Fernando Cabanillas
T-cell-rich B-cell lymphoma.
Blood 1993;82(5):1586-9.
1993: Meletios A Dimopoulos; Fernando Cabanillas; J Jack Lee; F Swan; L Fuller; Pamela K Allen; F B Hagemeister
Prognostic role of serum beta 2-microglobulin in Hodgkin's disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(6):1108-11.
1993: Razelle Kurzrock; J Redman; Fernando Cabanillas; D Jones; J Rothberg; Moshe Talpaz
Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms.
Cancer research 1993;53(9):2118-22.
1993: Jan C Liang; N M Bailey; G J Gabriel; Michael W Kattan; R Y Wang; F B Hagemeister; Fernando Cabanillas; Lillian M Fuller
A new chemotherapy regimen for treatment of Hodgkin's disease associated with minimal genotoxicity.
Leukemia & lymphoma 1993;9(6):503-8.
1993: Peter McLaughlin; Fernando Cabanillas; F B Hagemeister; F Swan; Jorge Romaguera; S Taylor; Maria A Rodriguez; W S Velasquez; J R Redman; Jordan U Gutterman
CHOP-Bleo plus interferon for stage IV low-grade lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(3):205-11.
1993: Richard J Ford; Archito Tamayo; Dai j Li; Fernando Cabanillas
Human B cell lymphomas: in vitro and in vivo studies on growth factors and cell growth.
Leukemia & lymphoma 1993;10 Suppl():51-6.
1993: J A Spinolo; Sundar Jagannath; W Velásquez; G Spitzer; Fernando Cabanillas; F Hagemeister; L J Horwitz; K A Dicke
Cisplatin-CBV with autologous bone marrow transplantation for relapsed Hodgkin's disease.
Leukemia & lymphoma 1993;9(1-2):71-7.
1993: Jorge Romaguera; WC Pugh; Rajyalakshmi Luthra; AM Goodacre; Fernando Cabanillas
The clinical relevance of t(14;18)/BCL-2 rearrangement and DEL 6q in diffuse large cell lymphoma and immunoblastic lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(1):51-4.
1993: P Soubeyran; Fernando Cabanillas; Ming-Sheng Lee
Analysis of the expression of the hybrid gene bcl-2/IgH in follicular lymphomas.
Blood 1993;81(1):122-7.
1993: Jose Rodriguez; WC Pugh; Jorge Romaguera; Fernando Cabanillas
Anaplastic Ki-1 + large-cell lymphoma.
Cancer investigation 1993;11(5):554-8.
1992: F B Hagemeister; L Fuller; Peter McLaughlin; M Rodriguez; Jorge Romaguera; F Swan; Fernando Cabanillas
NOVP and radiotherapy for early-staged Hodgkin's disease: an interim analysis.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3 Suppl 4():87-90.
1992: J R Redman; Fernando Cabanillas; W S Velasquez; Peter McLaughlin; F B Hagemeister; F Swan; Maria A Rodriguez; William Plunkett; Michael J Keating
Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(5):790-4.
1992: J A Spinolo; Fernando Cabanillas; D O Dixon; S M Khorana; Peter McLaughlin; W S Velasquez; F B Hagemeister; J R Redman; F Swan
Therapy of relapsed or refractory low-grade follicular lymphomas: factors associated with complete remission, survival and time to treatment failure.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3(3):227-32.
1992: Fernando Cabanillas; W S Velasquez; F B Hagemeister; Peter McLaughlin; J R Redman
Clinical, biologic, and histologic features of late relapses in diffuse large cell lymphoma.
Blood 1992;79(4):1024-8.
1992: Kenneth V I Rolston; P Berkey; Gerald P Bodey; Elias J Anaissie; Nancy Khardori; J H Joshi; M J Keating; F A Holmes; Fernando Cabanillas; Linda S Elting
A comparison of imipenem to ceftazidime with or without amikacin as empiric therapy in febrile neutropenic patients.
Archives of internal medicine 1992;152(2):283-91.
1992: Fernando Cabanillas
Non-Hodgkin's lymphomas: a review of the M.D. Anderson experience.
Seminars in oncology 1992;19(1 Suppl 1):11-3.
1992: Shiao Y Woo; Lillian M Fuller; J H Cundiff; Melissa L Bondy; F B Hagemeister; Peter McLaughlin; W S Velasquez; F Swan; Maria A Rodriguez; Fernando Cabanillas
Radiotherapy during pregnancy for clinical stages IA-IIA Hodgkin's disease.
International journal of radiation oncology, biology, physics 1992;23(2):407-12.
1991: Maria A Rodriguez; R J Ford; AM Goodacre; P Selvanayagam; Fernando Cabanillas; Albert Deisseroth
Chromosome 17- and p53 changes in lymphoma.
British journal of haematology 1991;79(4):575-82.
1991: P Litam; F Swan; Fernando Cabanillas; Susan L Tucker; Peter McLaughlin; F B Hagemeister; Maria A Rodriguez; W S Velasquez
Prognostic value of serum beta-2 microglobulin in low-grade lymphoma.
Annals of internal medicine 1991;114(10):855-60.
1991: Jorge Romaguera; Peter McLaughlin; LB North; D Dixon; K B Silvermintz; L A Garnsey; W S Velasquez; F B Hagemeister; Fernando Cabanillas
Multivariate analysis of prognostic factors in stage IV follicular low-grade lymphoma: a risk model.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(5):762-9.
1991: Steven M Kornblau; AM Goodacre; Fernando Cabanillas
Chromosomal abnormalities in adult non-endemic Burkitt's lymphoma and leukemia: 22 new reports and a review of 148 cases from the literature.
Hematological oncology 1991;9(2):63-78.
1991: Peter McLaughlin; L Fuller; J Redman; F Hagemeister; E Durr; P Allen; L Holmes; W Velasquez; F Swan; Fernando Cabanillas
Stage I-II low-grade lymphomas: a prospective trial of combination chemotherapy and radiotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1991;2 Suppl 2():137-40.
1990: F B Hagemeister; Fernando Cabanillas; W S Velásquez; Marvin L Meistrich; Jan C Liang; Peter McLaughlin; J R Redman; Jorge Romaguera; M A Rodríguez; F Swan
NOVP: a novel chemotherapeutic regimen with minimal toxicity for treatment of Hodgkin's disease.
Seminars in oncology 1990;17(6 Suppl 10):34-8; discussion 38-40.
1990: Fernando Cabanillas; M A Rodríguez; F Swan
Recent trends in the management of lymphomas at M.D. Anderson Cancer Center.
Seminars in oncology 1990;17(6 Suppl 10):28-32; discussion 32-3.
1990: J E Romagurea; W S Velasquez; K B Silvermintz; L B Fuller; F B Hagemeister; Peter McLaughlin; Fernando Cabanillas
Surgical debulking is associated with improved survival in stage I-II diffuse large cell lymphoma.
Cancer 1990;66(2):267-72.
1990: Nour Sneige; R H Dekmezian; Ruth Katz; T V Fanning; J L Lukeman; N F Ordoñez; Fernando Cabanillas
Morphologic and immunocytochemical evaluation of 220 fine needle aspirates of malignant lymphoma and lymphoid hyperplasia.
Acta cytologica 1990;34(3):311-22.
1990: Fernando Cabanillas
Ifosfamide combinations in lymphoma.
Seminars in oncology 1990;17(2 Suppl 4):58-62.
1990: R J Ford; AM Goodacre; I Ramirez; S R Mehta; Fernando Cabanillas
Establishment and characterization of human B-cell lymphoma cell lines using B-cell growth factor.
Blood 1990;75(6):1311-8.
1989: K M Taylor; Sundar Jagannath; G Spitzer; J A Spinolo; Susan L Tucker; B Fogel; Fernando Cabanillas; F B Hagemeister; L M Souza
Recombinant human granulocyte colony-stimulating factor hastens granulocyte recovery after high-dose chemotherapy and autologous bone marrow transplantation in Hodgkin's disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(12):1791-9.
1989: Bart Barlogie; W S Velasquez; Raymond Alexanian; Fernando Cabanillas
Etoposide, dexamethasone, cytarabine, and cisplatin in vincristine, doxorubicin, and dexamethasone-refractory myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(10):1514-7.
1989: F Swan; W S Velasquez; S Tucker; J R Redman; Maria A Rodriguez; Peter McLaughlin; F B Hagemeister; Fernando Cabanillas
A new serologic staging system for large-cell lymphomas based on initial beta 2-microglobulin and lactate dehydrogenase levels.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(10):1518-27.
1989: Fernando Cabanillas; Sen Pathak; G Grant; F B Hagemeister; Peter McLaughlin; F Swan; Maria A Rodriguez; J Trujillo; A Cork; J J Butler
Refractoriness to chemotherapy and poor survival related to abnormalities of chromosomes 17 and 7 in lymphoma.
The American journal of medicine 1989;87(2):167-72.
1989: W S Velasquez; Sundar Jagannath; Susan L Tucker; Lillian M Fuller; LB North; J R Redman; F Swan; F B Hagemeister; Peter McLaughlin; Fernando Cabanillas
Risk classification as the basis for clinical staging of diffuse large-cell lymphoma derived from 10-year survival data.
Blood 1989;74(2):551-7.
1989: T Terjanian; M B Blick; M Shtalrid; J T Manning; J M Trujillo; Fernando Cabanillas
Philadelphia chromosome without breakpoint cluster region rearrangement in a case of Lennert's lymphoma of suppressor phenotype.
Hematological oncology 1989;7(3):189-94.
1989: Fernando Cabanillas
Experience with ifosfamide combinations in malignant lymphomas.
Seminars in oncology 1989;16(1 Suppl 3):78-81.
1989: Ruth Katz; A Gritsman; Fernando Cabanillas; Christina V Fanning; R Dekmezian; Nelson G Ordonez; Bart Barlogie; J J Butler
Fine-needle aspiration cytology of peripheral T-cell lymphoma. A cytologic, immunologic, and cytometric study.
American journal of clinical pathology 1989;91(2):120-31.
1989: Fernando Cabanillas
Management of patients with low-grade follicular lymphoma.
American journal of clinical oncology 1989;12(1):81-7.
1989: J A Spinolo; Sundar Jagannath; K A Dicke; K E Smith; Fernando Cabanillas; F B Hagemeister; L J Horwitz; Peter McLaughlin; F Swan; G Spitzer
High-dose combination chemotherapy with cyclophosphamide, carmustine, etoposide, and autologous bone marrow transplantation in 60 patients with relapsed Hodgkin's disease: the M. D. Anderson experience.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1989;117():233-8.
1988: Bart Barlogie; Raymond Alexanian; L Smallwood; B Cheson; D Dixon; K Dicke; Fernando Cabanillas
Prognostic factors with high-dose melphalan for refractory multiple myeloma.
Blood 1988;72(6):2015-9.
1988: Peter McLaughlin; B M Osborne; D Johnston; P Jennings; J J Butler; Fernando Cabanillas; Bart Barlogie
Nucleic acid flow cytometry in large cell lymphoma.
Cancer research 1988;48(22):6614-9.
1988: Peter McLaughlin; W S Velasquez; J R Redman; W K Alfred Yung; F B Hagemeister; Maria A Rodriguez; Fernando Cabanillas
Chemotherapy with dexamethasone, high-dose cytarabine, and cisplatin for parenchymal brain lymphoma.
Journal of the National Cancer Institute 1988;80(17):1408-12.
1988: Fernando Cabanillas; Sen Pathak; J Trujillo; J Manning; R Katz; Peter McLaughlin; W S Velasquez; F B Hagemeister; AM Goodacre; A Cork
Frequent nonrandom chromosome abnormalities in 27 patients with untreated large cell lymphoma and immunoblastic lymphoma.
Cancer research 1988;48(19):5557-64.
1988: Fernando Cabanillas
A review and interpretation of cytogenetic abnormalities identified in Hodgkin's disease.
Hematological oncology 1988;6(3):271-4.
1988: Fernando Cabanillas; Sen Pathak; J Trujillo; G Grant; A Cork; F B Hagemeister; W S Velasquez; Peter McLaughlin; J Redman; R Katz
Cytogenetic features of Hodgkin's disease suggest possible origin from a lymphocyte.
Blood 1988;71(6):1615-7.
1988: C Ince; M Blick; M Lee; S Pathak; S Vadhan-Raj; P Selvanayagam; Jordan U Gutterman; Fernando Cabanillas
Bcl-1 gene rearrangements in B cell lymphoma.
Leukemia 1988;2(6):343-6.
1988: Fernando Cabanillas; W S Velasquez; Peter McLaughlin; Sundar Jagannath; F B Hagemeister; J R Redman; F Swan; Maria A Rodriguez
Results of recent salvage chemotherapy regimens for lymphoma and Hodgkin's disease.
Seminars in hematology 1988;25(2 Suppl 2):47-50.
1988: Elias J Anaissie; V Fainstein; Gerald P Bodey; Kenneth Rolston; Linda S Elting; Andrew Lamb; Fernando Cabanillas; K B McCredie
Randomized trial of beta-lactam regimens in febrile neutropenic cancer patients.
The American journal of medicine 1988;84(3 Pt 2):581-9.
1988: W S Velasquez; Fernando Cabanillas; P Salvador; Peter McLaughlin; M Fridrik; S Tucker; Sundar Jagannath; F B Hagemeister; J R Redman; F Swan
Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP).
Blood 1988;71(1):117-22.
1987: D O Dixon; Peter McLaughlin; F B Hagemeister; Emil J Freireich; L M Fuller; Fernando Cabanillas; Edmund Gehan
Reporting outcomes in Hodgkin's disease and lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(10):1670-2.
1987: F B Hagemeister; N Tannir; Peter McLaughlin; P Salvador; S Riggs; W S Velasquez; Fernando Cabanillas
MIME chemotherapy (methyl-GAG, ifosfamide, methotrexate, etoposide) as treatment for recurrent Hodgkin's disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(4):556-61.
1987: Fernando Cabanillas; F B Hagemeister; Peter McLaughlin; W S Velasquez; S Riggs; L Fuller; T Smith
Results of MIME salvage regimen for recurrent or refractory lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(3):407-12.
1987: Fernando Cabanillas; Sen Pathak; A Zander; AM Goodacre; R Katz; N Sneige; J Trujillo; A Cork; J Manning; J J Butler
Monosomy 21, partial duplication of chromosome 11, and structural abnormality of chromosome 1q21 in a case of lymphoma developing in a transplant recipient: characteristic abnormalities of secondary lymphoma?
Cancer genetics and cytogenetics 1987;24(1):7-10.
1986: Sundar Jagannath; K A Dicke; J O Armitage; Fernando Cabanillas; L J Horwitz; L Vellekoop; A R Zander; G Spitzer
High-dose cyclophosphamide, carmustine, and etoposide and autologous bone marrow transplantation for relapsed Hodgkin's disease.
Annals of internal medicine 1986;104(2):163-8.
1985: S P Kalter; S A Riggs; Fernando Cabanillas; J J Butler; F B Hagemeister; P W Mansell; G R Newell; W S Velasquez; P Salvador; Bart Barlogie
Aggressive non-Hodgkin's lymphomas in immunocompromised homosexual males.
Blood 1985;66(3):655-9.
1984: H M Kantarjian; Peter McLaughlin; L M Fuller; D O Dixon; B M Osborne; Fernando Cabanillas
Follicular large cell lymphoma: analysis and prognostic factors in 62 patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1984;2(7):811-9.
1984: M F da Cunha; M L Meistrich; Lillian M Fuller; J H Cundiff; F B Hagemeister; W S Velasquez; Peter McLaughlin; S A Riggs; Fernando Cabanillas; P G Salvador
Recovery of spermatogenesis after treatment for Hodgkin's disease: limiting dose of MOPP chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1984;2(6):571-7.
1983: N Tannir; F Hagemeister; W Velasquez; Fernando Cabanillas
Long-term follow-up with ABDIC salvage chemotherapy of MOPP-resistant Hodgkin's disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1983;1(7):432-9.